Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol oral solution for pediatric postoperative acute pain
2012-004359-35Phase 3
- Sponsor
- Janssen Research & Development
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of tapentadol in postoperative pain, sponsored by Janssen Research & Development. Primary endpoint: Total supplemental opioid analgesic medication use after first IMP intake.
02
Drugs
tapentadol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2012-004359-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004359-35.